Effects of dapagliflozin on major adverse kidney and cardiovascular (CV) events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

Effect of Amlodipine in Stroke and Myocardial Infarction (MI): A Systematic Review and Meta-analysis

Comparative clinical study evaluating the effect of adding vildagliptin versus glimepiride to ongoing metformin therapy on diabetic patients with symptomatic coronary artery disease (CAD)

Reduced Mortality With Ondansetron Use in SARS-CoV2-Infected Inpatients

The impact of vildagliptin on the daily glucose profle and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial

Effect of Rosuvastatin on Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Prospective Interventional Study

The efficacy and safety of azithromycin in chronic respiratory diseases related cough

Vildagliptin is a safe and powerful oral antidiabetic drug for elderly adults with type 2 diabetes

Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI): a meta-analysis of randomized controlled trials with GRADE qualification of available evidence

Telmisartan inhibits the NLRP3 inflammasome by activating the PI3K pathway in neural stem cells injured by oxygen-glucose deprivation (OGD)